title: Recent advances in the management of transient ischaemic attack: a clinical review.
abstract: Transient ischaemic attack (TIA) if untreated carries a high risk of early stroke and is associated with poorer long-term survival. There have been recent advances in the understanding of TIA, its investigations, management and organisation of services for patient care. Clinically, patients are diagnosed TIA if they have transient sudden-onset focal neurological symptoms which usually completely and rapidly resolve by presentation. Patients with residual symptoms should be evaluated as potentially having stroke, if they present within 4.5 h of onset, should be urgently evaluated for their potential eligibility for thrombolysis. TIA patients should receive rapid attention with essential investigations, including brain imaging, electrocardiograph and carotid ultrasound. Immediate administration of an antiplatelet agent is recommended after brain imaging, with subsequent attention to preventing or treating other mechanistic factors. There is emerging evidence that TIA patients can be managed safely in the outpatient setting after initial rapid management in emergency departments as part of a structured clinical pathway supervised by stroke specialists. Clinical systems of management may require approaches individualised to the healthcare setting, while adopting the central aspects of rapid management.
authors.affiliation: Stroke Unit, Department of Neurosciences, Monash Medical Centre, Stroke and Aging Research Group, Department of Medicine, Monash University, Melbourne, Victoria, Australia. thanh.phan@monash.edu
authors.forename: T G
authors.initials: TG
authors.lastname: Phan
authors.forename: L
authors.initials: L
authors.lastname: Sanders
authors.forename: V
authors.initials: V
authors.lastname: Srikanth
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003952:Diagnostic Imaging / Q000639:trends; D019468:Disease Management; D004562:Electrocardiography / Q000639:trends; D006801:Humans; D002546:Ischemic Attack, Transient / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D040242:Risk Reduction Behavior; D020521:Stroke / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control
chemical_list: D000959:Antihypertensive Agents; D010975:Platelet Aggregation Inhibitors